The round was led by Eurazeo, with participation from Amazon's Alexa Fund, WE International, Kurma Partners, Vives Fund, Majycc (an UI Investissement fund), Namur Invest, Seventure Partners, Investsud, Sambrinvest, Noshaq, IMBC and Invest.BW.

Founded in 2015, Sunrise Group® is a pioneer in sleep health technology. The company first developed an FDA-cleared mandibular movement sensor, a lightweight at-home diagnostic device for sleep apnea that has been validated in peer-reviewed studies and endorsed by leading sleep experts. Today, Sunrise builds on that breakthrough to develop advanced hardware and software to detect, monitor, and treat sleep disorders, and brings this expertise to Dreem Health®, its U.S. digital sleep clinic. Headquartered in Belgium with offices in France and the United States, the team brings together leaders in sleep research, patient care, and medical technology.